Product Program year 2021 Source: CMS Open Payments

Sumadan

Drug Dermatology

NDC 43538-191-16

Open in the dashboard

General payments

$2,933

82 payments

Research payments

$0

0 payments

Through program year 2021, $2,933 in general payments and $0 in research payments were reported against Sumadan (Dermatology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2021 General $153 5
2020 General $476 9
2019 General $2,304 68

Breakdown

Who paid General payments · program years 2019–2021
  1. Medimetriks Pharmaceuticals, Inc. $2,933 82 payments
Top recipients General payments · program year 2021
  1. Tina Funt Dermatology · Garden City, NY $119 77% · 2 payments
  2. Sami Abbasi Dermatology · Woodhaven, MI $16 10% · 1 payment
  3. Milton Moore Dermatology · San Antonio, TX $10 6% · 1 payment
  4. Michael Fastenberg Dermatology · Smithtown, NY $10 6% · 1 payment

Each share is of general payments naming this product in 2021.

Specialties paid General payments · program year 2021
  1. Dermatology $153 100% · 4 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2021
  1. New York $119 77% · 1 recipient
  2. Michigan $16 10% · 1 recipient
  3. Texas $10 6% · 1 recipient
  4. North Carolina $10 6% · 1 recipient

Each share is of general payments naming this product in 2021 where a state was reported.

82 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record